Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT07525076
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- HIV Infections
- Syphilis Infection
Eligibility Criteria
- Sex
- FEMALE
- Age
- 14 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Chembio HIV/Syphilis rapid Point of Care (POC) test — DIAGNOSTIC_TESTParticipants will undergo dual rapid HIV/syphilis testing by fingerstick using the Chembio DPP® HIV-Syphilis System.
- Laboratory-based HIV and syphilis testing — DIAGNOSTIC_TESTLaboratory-based HIV and syphilis testing
Study Details
The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual rapid testing improves early initiation of HIV therapy in pregnant patients with newly identified HIV infection.
Key Dates
- Start date
- Apr 15, 2026
- Status verified
- Apr 2026
- Primary completion
- May 31, 2028
- Completion
- May 31, 2028
Study Design
- Enrollment
- 1,400 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Chembio HIV/Syphilis rapid POC test plus standard of care lab based HIV/Syphilis testing
Primary Outcome Measure
Number of participants that tested for HIV [ Time Frame: Baseline ]
Central Contacts
- Irene Stafford, M.D., M.S., M.P.H.(713) 500-6412
- Robin L Beach(713) 500-5940
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By condition
By specialty
Related Studies
- A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult ParticipantsPHASE1 · Recruiting · ViiV Healthcare · Orlando, Florida
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)PHASE2 · Recruiting · Priscilla Hsue, MD · Los Angeles, California
- Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in PediatricsPHASE1/PHASE2 · Recruiting · ViiV Healthcare · Long Beach, California
- Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing HomelessnessRecruiting · The University of Texas Health Science Center, Houston · Houston, Texas